The effectiveness of a fixed double combination (bisoprolol, perindopril) in patients with stable coronary artery disease and arterial hypertension in different degrees

The use of beta-blockers (bisoprolol) and ACE inhibitors (perindopril) is pathogenetically and clinically justified in patients with stable coronary artery disease (CAD) and concomitant arterial hypertension (AH) . The study showed that prescribing a fixed combination of previously used drugs (perindopril, bisoprolol) for 4 weeks in patients with clinical symptoms or documented CAD can effectively reduce heart rate (HR) and blood pressure (BP) (heart rate levels ≤ 70 bpm were reached in 84.9%, blood pressure ≤ 140/90 mm Hg - 86.9% of patients), reduces the number of angina attacks from 4.4 to 2.6 per week and the need for nitroglycerin - from 4.8 to 2.7 tablets per week, and improve adherence to therapy (66.5% of patients).